International scientific guideline: Note for guidance on clinical investigation of medicinal products for the treatment of peripheral arterial occlusive disease
CPMP/EWP/714/98 Rev 1 adopted by the Therapeutic Goods Administration (TGA)
Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.